Avadel Pharmaceuticals (AVDL) Receivables - Other (2018 - 2021)
Historic Receivables - Other for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Q4 2021 value amounting to $1.0 million.
- Avadel Pharmaceuticals' Receivables - Other fell 2324.56% to $1.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.0 million, marking a year-over-year decrease of 2324.56%. This contributed to the annual value of $1.0 million for FY2021, which is 2324.56% down from last year.
- According to the latest figures from Q4 2021, Avadel Pharmaceuticals' Receivables - Other is $1.0 million, which was down 2324.56% from $1.4 million recorded in Q4 2020.
- In the past 5 years, Avadel Pharmaceuticals' Receivables - Other ranged from a high of $6.5 million in Q2 2018 and a low of $1.0 million during Q4 2021
- Its 4-year average for Receivables - Other is $4.3 million, with a median of $5.9 million in 2019.
- In the last 5 years, Avadel Pharmaceuticals' Receivables - Other crashed by 757.79% in 2019 and then crashed by 7375.92% in 2020.
- Quarter analysis of 4 years shows Avadel Pharmaceuticals' Receivables - Other stood at $6.2 million in 2018, then plummeted by 70.78% to $1.8 million in 2019, then fell by 24.88% to $1.4 million in 2020, then fell by 23.25% to $1.0 million in 2021.
- Its Receivables - Other stands at $1.0 million for Q4 2021, versus $1.4 million for Q4 2020 and $1.6 million for Q2 2020.